vs
Side-by-side financial comparison of ALBANY INTERNATIONAL CORP (AIN) and BALCHEM CORP (BCPC). Click either name above to swap in a different company.
ALBANY INTERNATIONAL CORP is the larger business by last-quarter revenue ($321.2M vs $263.6M, roughly 1.2× BALCHEM CORP). BALCHEM CORP runs the higher net margin — 14.9% vs 4.3%, a 10.6% gap on every dollar of revenue. On growth, ALBANY INTERNATIONAL CORP posted the faster year-over-year revenue change (12.0% vs 9.8%). Over the past eight quarters, BALCHEM CORP's revenue compounded faster (4.9% CAGR vs 1.2%).
Albany International Corp is a global advanced materials and industrial technology company. It operates two core segments: Machine Clothing producing custom engineered fabrics for paper and other industrial manufacturing processes, and Engineered Composites developing high-performance composite components primarily for the aerospace and defense sectors, serving customers across North America, Europe, Asia and other global regions.
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
AIN vs BCPC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $321.2M | $263.6M |
| Net Profit | $13.9M | $39.2M |
| Gross Margin | 31.1% | 35.6% |
| Operating Margin | 9.3% | 19.8% |
| Net Margin | 4.3% | 14.9% |
| Revenue YoY | 12.0% | 9.8% |
| Net Profit YoY | -21.5% | 16.8% |
| EPS (diluted) | $0.56 | $1.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $321.2M | $263.6M | ||
| Q3 25 | $261.4M | $267.6M | ||
| Q2 25 | $311.4M | $255.5M | ||
| Q1 25 | $288.8M | $250.5M | ||
| Q4 24 | $286.9M | $240.0M | ||
| Q3 24 | $298.4M | $239.9M | ||
| Q2 24 | $332.0M | $234.1M | ||
| Q1 24 | $313.3M | $239.7M |
| Q4 25 | $13.9M | $39.2M | ||
| Q3 25 | $-97.8M | $40.3M | ||
| Q2 25 | $9.2M | $38.3M | ||
| Q1 25 | $17.4M | $37.1M | ||
| Q4 24 | $17.7M | $33.6M | ||
| Q3 24 | $18.0M | $33.8M | ||
| Q2 24 | $24.6M | $32.1M | ||
| Q1 24 | $27.3M | $29.0M |
| Q4 25 | 31.1% | 35.6% | ||
| Q3 25 | -19.1% | 35.7% | ||
| Q2 25 | 31.3% | 36.4% | ||
| Q1 25 | 33.4% | 35.2% | ||
| Q4 24 | 31.5% | 36.0% | ||
| Q3 24 | 30.3% | 35.6% | ||
| Q2 24 | 33.9% | 35.5% | ||
| Q1 24 | 34.7% | 34.0% |
| Q4 25 | 9.3% | 19.8% | ||
| Q3 25 | -44.6% | 20.4% | ||
| Q2 25 | 7.2% | 20.1% | ||
| Q1 25 | 9.8% | 20.4% | ||
| Q4 24 | 8.5% | 19.8% | ||
| Q3 24 | 8.4% | 20.0% | ||
| Q2 24 | 12.9% | 19.6% | ||
| Q1 24 | 12.4% | 17.4% |
| Q4 25 | 4.3% | 14.9% | ||
| Q3 25 | -37.4% | 15.1% | ||
| Q2 25 | 2.9% | 15.0% | ||
| Q1 25 | 6.0% | 14.8% | ||
| Q4 24 | 6.2% | 14.0% | ||
| Q3 24 | 6.0% | 14.1% | ||
| Q2 24 | 7.4% | 13.7% | ||
| Q1 24 | 8.7% | 12.1% |
| Q4 25 | $0.56 | $1.21 | ||
| Q3 25 | $-3.37 | $1.24 | ||
| Q2 25 | $0.31 | $1.17 | ||
| Q1 25 | $0.56 | $1.13 | ||
| Q4 24 | $0.57 | $1.03 | ||
| Q3 24 | $0.57 | $1.03 | ||
| Q2 24 | $0.79 | $0.98 | ||
| Q1 24 | $0.87 | $0.89 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $112.3M | $74.6M |
| Total DebtLower is stronger | $455.7M | — |
| Stockholders' EquityBook value | $726.2M | $1.3B |
| Total Assets | $1.7B | $1.7B |
| Debt / EquityLower = less leverage | 0.63× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $112.3M | $74.6M | ||
| Q3 25 | $108.3M | $65.1M | ||
| Q2 25 | $106.7M | $65.4M | ||
| Q1 25 | $119.4M | $49.9M | ||
| Q4 24 | $115.3M | $49.5M | ||
| Q3 24 | $127.2M | $73.7M | ||
| Q2 24 | $116.4M | $63.7M | ||
| Q1 24 | $125.4M | $60.3M |
| Q4 25 | $455.7M | — | ||
| Q3 25 | $480.6M | — | ||
| Q2 25 | $444.7M | — | ||
| Q1 25 | $416.4M | — | ||
| Q4 24 | $318.5M | — | ||
| Q3 24 | $362.2M | — | ||
| Q2 24 | $377.1M | — | ||
| Q1 24 | $439.1M | — |
| Q4 25 | $726.2M | $1.3B | ||
| Q3 25 | $739.3M | $1.3B | ||
| Q2 25 | $888.6M | $1.3B | ||
| Q1 25 | $900.0M | $1.2B | ||
| Q4 24 | $943.5M | $1.1B | ||
| Q3 24 | $991.0M | $1.2B | ||
| Q2 24 | $967.5M | $1.1B | ||
| Q1 24 | $967.5M | $1.1B |
| Q4 25 | $1.7B | $1.7B | ||
| Q3 25 | $1.7B | $1.7B | ||
| Q2 25 | $1.7B | $1.7B | ||
| Q1 25 | $1.7B | $1.6B | ||
| Q4 24 | $1.6B | $1.6B | ||
| Q3 24 | $1.8B | $1.6B | ||
| Q2 24 | $1.8B | $1.6B | ||
| Q1 24 | $1.8B | $1.6B |
| Q4 25 | 0.63× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.50× | — | ||
| Q1 25 | 0.46× | — | ||
| Q4 24 | 0.34× | — | ||
| Q3 24 | 0.37× | — | ||
| Q2 24 | 0.39× | — | ||
| Q1 24 | 0.45× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $73.7M | $67.3M |
| Free Cash FlowOCF − Capex | $51.4M | — |
| FCF MarginFCF / Revenue | 16.0% | — |
| Capex IntensityCapex / Revenue | 6.9% | — |
| Cash ConversionOCF / Net Profit | 5.31× | 1.72× |
| TTM Free Cash FlowTrailing 4 quarters | $82.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $73.7M | $67.3M | ||
| Q3 25 | $43.9M | $65.6M | ||
| Q2 25 | $32.7M | $47.3M | ||
| Q1 25 | $2.1M | $36.5M | ||
| Q4 24 | $78.5M | $52.3M | ||
| Q3 24 | $47.0M | $51.3M | ||
| Q2 24 | $83.4M | $45.0M | ||
| Q1 24 | $9.6M | $33.4M |
| Q4 25 | $51.4M | — | ||
| Q3 25 | $25.9M | — | ||
| Q2 25 | $18.8M | — | ||
| Q1 25 | $-13.5M | — | ||
| Q4 24 | $60.2M | — | ||
| Q3 24 | $31.6M | — | ||
| Q2 24 | $63.6M | — | ||
| Q1 24 | $-17.3M | — |
| Q4 25 | 16.0% | — | ||
| Q3 25 | 9.9% | — | ||
| Q2 25 | 6.0% | — | ||
| Q1 25 | -4.7% | — | ||
| Q4 24 | 21.0% | — | ||
| Q3 24 | 10.6% | — | ||
| Q2 24 | 19.2% | — | ||
| Q1 24 | -5.5% | — |
| Q4 25 | 6.9% | — | ||
| Q3 25 | 6.9% | — | ||
| Q2 25 | 4.5% | — | ||
| Q1 25 | 5.4% | — | ||
| Q4 24 | 6.4% | — | ||
| Q3 24 | 5.2% | — | ||
| Q2 24 | 6.0% | — | ||
| Q1 24 | 8.6% | — |
| Q4 25 | 5.31× | 1.72× | ||
| Q3 25 | — | 1.63× | ||
| Q2 25 | 3.56× | 1.23× | ||
| Q1 25 | 0.12× | 0.98× | ||
| Q4 24 | 4.44× | 1.56× | ||
| Q3 24 | 2.61× | 1.52× | ||
| Q2 24 | 3.39× | 1.40× | ||
| Q1 24 | 0.35× | 1.15× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AIN
| Transferred At Point In Time | $176.5M | 55% |
| Engineered Composites Other | $99.3M | 31% |
| Engineered Composites ASC | $44.5M | 14% |
| Transferred Over Time | $1.0M | 0% |
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
